Current and emerging pharmacological treatments for sarcoidosis: A review

96Citations
Citations of this article
99Readers
Mendeley users who have this article in their library.

Abstract

The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis. © 2013 Beegle et al, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Beegle, S. H., Barba, K., Gobunsuy, R., & Judson, M. A. (2013, April 11). Current and emerging pharmacological treatments for sarcoidosis: A review. Drug Design, Development and Therapy. https://doi.org/10.2147/DDDT.S31064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free